Search research articles
Contact Us
Filters
Showing results (121-130 of 480) with videos related to
Page
of 48
Sort By:
Journal of Medicinal Chemistry
|
December 18, 2015
Design of High-Affinity Stapled Peptides To Target the Repressor Activator Protein 1 (RAP1)/Telomeric Repeat-Binding Factor 2 (TRF2) Protein-Protein Interaction in the Shelterin Complex
Xu Ran, Liu Liu, Chao-Yie Yang, et al.
Pharmacological Research
|
October 9, 2008
-(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro
Jill A Macoska, Shreelekha Adsule, Kwanchanit Tantivejkul, et al.
Journal of Medicinal Chemistry
|
July 9, 2020
Artificial Intelligence in Drug Discovery: Into the Great Wide Open
Jürgen Bajorath, Steven Kearnes, W Patrick Walters, et al.
BMC Biotechnology
|
May 28, 2013
Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins
Jianting Long, Liu Liu, Zaneta Nikolovska-Coleska, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors
Cindy Gomez, Longchuan Bai, Jian Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2010
Cyclopeptide Smac mimetics as antagonists of IAP proteins
Haiying Sun, Liu Liu, Jianfeng Lu, et al.
Biochemistry
|
September 1, 2009
Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction
Steven A Kawamoto, Andrea D Thompson, Adriana Coleska, et al.
Molecular Cancer Therapeutics
|
January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance
Christopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
Biopharmaceutics & Drug Disposition
|
July 2, 2013
Physiologically based pharmacokinetic and pharmacodynamic modeling of an antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in a mouse xenograft model of human breast cancer
Tao Zhang, Yanyan Li, Peng Zou, et al.
Psychopharmacology
|
January 6, 2011
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity
Gregory T Collins, Yen Nhu-Thi Truong, Beth Levant, et al.
Page
of 48
Search research articles
Search
Showing results (121-130 of 480) with videos related to
Sort By:
Page
of 48
Journal of Medicinal Chemistry
|
December 18, 2015
Design of High-Affinity Stapled Peptides To Target the Repressor Activator Protein 1 (RAP1)/Telomeric Repeat-Binding Factor 2 (TRF2) Protein-Protein Interaction in the Shelterin Complex
Xu Ran, Liu Liu, Chao-Yie Yang, et al.
Pharmacological Research
|
October 9, 2008
-(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro
Jill A Macoska, Shreelekha Adsule, Kwanchanit Tantivejkul, et al.
Journal of Medicinal Chemistry
|
July 9, 2020
Artificial Intelligence in Drug Discovery: Into the Great Wide Open
Jürgen Bajorath, Steven Kearnes, W Patrick Walters, et al.
BMC Biotechnology
|
May 28, 2013
Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins
Jianting Long, Liu Liu, Zaneta Nikolovska-Coleska, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 27, 2009
Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors
Cindy Gomez, Longchuan Bai, Jian Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 6, 2010
Cyclopeptide Smac mimetics as antagonists of IAP proteins
Haiying Sun, Liu Liu, Jianfeng Lu, et al.
Biochemistry
|
September 1, 2009
Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction
Steven A Kawamoto, Andrea D Thompson, Adriana Coleska, et al.
Molecular Cancer Therapeutics
|
January 20, 2005
(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-X(L)-mediated apoptosis resistance
Christopher L Oliver, Michelle B Miranda, Sanjeev Shangary, et al.
Biopharmaceutics & Drug Disposition
|
July 2, 2013
Physiologically based pharmacokinetic and pharmacodynamic modeling of an antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in a mouse xenograft model of human breast cancer
Tao Zhang, Yanyan Li, Peng Zou, et al.
Psychopharmacology
|
January 6, 2011
Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity
Gregory T Collins, Yen Nhu-Thi Truong, Beth Levant, et al.
Page
of 48